reference/7914780

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7914780

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Review
endingPage	231
issn	0269-4727 1365-2710
issueIdentifier	3
pageRange	209-231
publicationName	Journal of Clinical Pharmacy and Therapeutics
startingPage	209
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0c9844bbdee9205c4154baa99844748d
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_31c5e1d95cf66d5e41fd8c54558d63c0
bibliographicCitation	Xie S, Furjanic MA, Ferrara JJ, McAndrew NR, Ardino EL, Ngondara A, Bernstein Y, Thomas KJ, Kim E, Walker JM, Nagar S, Ward SJ, Raffa RB. The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use. J Clin Pharm Ther. 2007 Jun;32(3):209–31. doi: 10.1111/j.1365-2710.2007.00817.x. PMID: 17489873.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_939f630821e5d1d6c791bbbbf9845c3a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_87c7dff911d499d784bd4eff2a17a394 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_748603f0252f9a77a7e053b952b920f1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_41f3e0e38146fc06efbe15c438e347a9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7f966e6d0e17aa4a9e3d82bb2ed2df01 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5eec5a4e86ae89b72ac5bc93589cc7f2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9a4b973823c301836153b653c9d66976 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_07e4379669ab37fe3636b796db9b4a98 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a99236123c259346b6845f835ae8fc3f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a10d91e19f584c6ca1681a1ebedce1f9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e9daec8d1904343e7a9efa5d6d1ad1a6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6e9a2b1768cf04ca71fb206db4efe4eb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_872449cdabb974d39add45647f4981cc
date	200706
identifier	https://doi.org/10.1111/j.1365-2710.2007.00817.x https://pubmed.ncbi.nlm.nih.gov/17489873
isPartOf	https://portal.issn.org/resource/ISSN/1365-2710 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4608 https://portal.issn.org/resource/ISSN/0269-4727
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1receptor antagonism ? or inverse agonism ? as potential obesity treatment and other therapeutic use
discusses	http://id.nlm.nih.gov/mesh/M0016885 http://id.nlm.nih.gov/mesh/M0018226 http://id.nlm.nih.gov/mesh/M0155202 http://id.nlm.nih.gov/mesh/M0028922 http://id.nlm.nih.gov/mesh/M0573109 http://id.nlm.nih.gov/mesh/M0573119 http://id.nlm.nih.gov/mesh/M0235470
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b278f6fa681694fa5d22a196adf47fef http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10420 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104850 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8679 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281515

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128482492 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128348432 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID99443236

Total number of triples: 50.